1. Home
  2. PRTA vs API Comparison

PRTA vs API Comparison

Compare PRTA & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • API
  • Stock Information
  • Founded
  • PRTA 2012
  • API 2013
  • Country
  • PRTA Ireland
  • API United States
  • Employees
  • PRTA N/A
  • API N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • API Computer Software: Prepackaged Software
  • Sector
  • PRTA Health Care
  • API Technology
  • Exchange
  • PRTA Nasdaq
  • API Nasdaq
  • Market Cap
  • PRTA 472.1M
  • API 343.2M
  • IPO Year
  • PRTA N/A
  • API 2020
  • Fundamental
  • Price
  • PRTA $8.20
  • API $3.45
  • Analyst Decision
  • PRTA Buy
  • API Strong Buy
  • Analyst Count
  • PRTA 10
  • API 1
  • Target Price
  • PRTA $14.86
  • API $6.00
  • AVG Volume (30 Days)
  • PRTA 1.2M
  • API 508.9K
  • Earning Date
  • PRTA 08-04-2025
  • API 08-18-2025
  • Dividend Yield
  • PRTA N/A
  • API N/A
  • EPS Growth
  • PRTA N/A
  • API N/A
  • EPS
  • PRTA N/A
  • API N/A
  • Revenue
  • PRTA $10,341,000.00
  • API $133,554,000.00
  • Revenue This Year
  • PRTA N/A
  • API $7.20
  • Revenue Next Year
  • PRTA $389.77
  • API $11.26
  • P/E Ratio
  • PRTA N/A
  • API N/A
  • Revenue Growth
  • PRTA N/A
  • API N/A
  • 52 Week Low
  • PRTA $4.32
  • API $1.78
  • 52 Week High
  • PRTA $22.83
  • API $6.99
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.73
  • API 40.21
  • Support Level
  • PRTA $8.05
  • API $3.48
  • Resistance Level
  • PRTA $8.73
  • API $3.67
  • Average True Range (ATR)
  • PRTA 0.38
  • API 0.19
  • MACD
  • PRTA -0.05
  • API -0.02
  • Stochastic Oscillator
  • PRTA 47.62
  • API 10.17

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

Share on Social Networks: